TCR2 Therapeutics Inc. buy BiotechBee
Start price
04.02.23
/
50%
€1.31
Target price
04.02.24
€3.00
Performance (%)
34.48%
End price
05.05.23
€1.76
Summary
This prediction ended on 05.05.23 with a price of €1.76. With a performance of 34.48% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
TCR2 Therapeutics Inc. | - | - | - |
iShares Core DAX® | 0.039% | 0.567% | 12.281% |
iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% |
iShares Nikkei 225® | -2.389% | -1.434% | 8.335% |
iShares S&P 500 | -2.115% | -2.351% | 22.061% |
According to BiotechBee what are the pros and cons of TCR2 Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Tcr2 Therapeutics Inc. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Tcr2 Therapeutics Inc.
Buy beendet